Therapeutic Drug Monitoring Data
A Concise Guide
- 4th Edition - September 14, 2019
- Latest edition
- Authors: Amitava Dasgupta, Matthew Krasowski
- Language: English
Therapeutic Drug Monitoring Data: A Concise Guide, Fourth Edition serves as a ready resource of information on commonly monitored drugs that will help readers make decisions… Read more
Early spring sale
Nurture your knowledge
Grow your expertise with up to 25% off trusted resources.
Description
Description
Therapeutic Drug Monitoring Data: A Concise Guide, Fourth Edition serves as a ready resource of information on commonly monitored drugs that will help readers make decisions relating to the monitoring and interpretation of results. It is an easy-to-read source of information on intended use, pharmacokinetics, therapeutic range, and toxic concentrations, as well as bioavailability, disposition, metabolism and the excretion of commonly monitored therapeutic drugs. This fully updated fourth edition includes sections on new anticonvulsants, anti-depressant and anti-HIV drugs, new drugs for advanced cancer treatment, and thoroughly updated chapters that address new pitfalls and problems in the lab.
Key features
Key features
- Serves as a ready resource of information for commonly monitored drugs
- Presents a useful, quick guide for those making decisions related to monitoring and interpretation of results
- Provides concise, easily digestible content for clinical laboratory scientists, toxicologists and clinicians
Readership
Readership
Table of contents
Table of contents
Product details
Product details
- Edition: 4
- Latest edition
- Published: September 14, 2019
- Language: English
About the authors
About the authors
AD
Amitava Dasgupta
Amitava Dasgupta received his Ph. D in chemistry from Stanford University and completed his fellowship training in Clinical Chemistry from the Department of Laboratory Medicine at the University of Washington School of Medicine at Seattle. He is board certified in both Toxicology and Clinical Chemistry by the American Board of Clinical Chemistry. Currently, he is a tenured Full Professor of Pathology and Laboratory Medicine at the University of Kansas Medical Center and Director of Clinical Laboratories at the University of Kansas Hospital. Prior to this appointment he was a tenured Professor of Pathology and Laboratory Medicine at the University of Texas McGovern medical School from February 1998 to April 2022. He has 252 papers to his credit. He is in the editorial board of four journals including Therapeutic Drug Monitoring, Clinica Chimica Acta, Archives of Pathology and Laboratory Medicine, and Journal of Clinical Laboratory Analysis.
MK